GTXi (GTXI) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
GTXi (GTXI)

An SI Board Since March 2005

Posts	SubjectMarks	Bans	Symbol
85	11	0	GTXI

Emcee: tuck	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
35	Both wilder and pgs showing up on the same day. How do you like that.	kenhott	-	7/18/2007
34	So something about the trial's power just now dawned on Leerink? They'v	keokalani'nui	-	7/18/2007
33	hey tuck I've pasted the last conference call, where the CEO goes into very	former_pgs	-	7/18/2007
32	Hey PGS, you still looking at this? Leerink downgraded on concerns about the AD	tuck	-	7/18/2007
31	GTx Initiates Phase IIb Ostarine Clinical Trial For Cancer Cachexia Tuesday July	tnsaf	-	7/3/2007
30	Thanks Wilder. I appreciate the reply. Everything looks pretty "clean"	former_pgs	-	5/16/2007
29	I've owned it off and on since 2004--mostly on since last year. It is in my	keokalani'nui	-	5/15/2007
28	Have started looking at this company and everything seems to be reasonable on th	former_pgs	-	5/15/2007
27	GTx to Host an Analyst Day to Provide an Update on ACAPODENE Phase III Clinical	tnsaf	-	4/15/2007
26	GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at P	tnsaf	-	2/23/2007
25	GTx Announces Registered Direct Common Stock Offering of $60.8 Million Wednesday	keokalani'nui	-	12/13/2006
24	GTx Announces That Ostarine Achieved Primary Endpoint of Lean Body Mass and a Se	keokalani'nui	-	12/8/2006
23	GTx Announces Conference Call and Webcast to Discuss Ostarine Phase II Clinical	keokalani'nui	-	12/7/2006
22	Company now REALLY needs to do a secondary here. Hello!	keokalani'nui	-	12/1/2006
21	Serms vs aromatase inh for BPH. Message 22982061	keokalani'nui	-	11/6/2006
20	I take it back (next news only modest). The ostarine data will be more importan	keokalani'nui	-	11/2/2006
19	Unfortunately the next news event will only be modest, an Asian license for acad	keokalani'nui	-	10/29/2006
18	Just listened to the UBS presentation, which may be gone by the time you read th	tuck	-	10/28/2006
17	Thanks for the heads up. I haven't researched this one recently. Need to f	tuck	-	10/28/2006
16	Company needs to do a secondary here.	keokalani'nui	-	10/28/2006
15	I own some. Can't see getting hurt by it for a while. FLW.	keokalani'nui	-	9/7/2006
14	I'm on the sidelines at the moment, but interested.	nigel bates	-	9/7/2006
13	Solidly strategic deal. Still have to buck up the EU IP though. Licensing agre	keokalani'nui	-	9/7/2006
12	Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapod	nigel bates	-	9/7/2006
11	Thanks for the link and Info. It is my understanding that they might indeed fac	idos	-	6/4/2006

Go to reply# or date (mm/dd/yy):